MAP1LC3A and neoplasm: More recently, we have shown that neratinib is capable of inducing LC3-associated phagocytosis (LAP), which requires expression of the protein Rubicon; knock down of Rubicon was significantly more protective than knock down of Beclin1 or ATG5 at preventing tumor cell killing (Figure 13B) (22).